Postpolio syndrome: unanswered questions regarding cause, course, risk factors, and therapies

The Lancet Neurology

Volumn 9, Issue 6, 2010, Pages 561-563

  Nollet, Frans ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; POLIOMYELITIS VACCINE;

BEHAVIOR MODIFICATION; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; FOLLOW UP; HUMAN; INFLAMMATION; LETTER; LIFESTYLE MODIFICATION; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHYSIOTHERAPY; POLIOMYELITIS; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR;

AGING; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; MUSCLE, SKELETAL; POSTPOLIOMYELITIS SYNDROME; REVIEW LITERATURE AS TOPIC; RISK FACTORS;

EID: 77952319080     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70110-1     Document Type: Letter

References (12)

1. Weinstein L. Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis. N Engl J Med 257 (1957) 47-52
2. Lassen H.C. A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency. Lancet 1 (1953) 37-41
3. Berthelsen P.G., and Cronqvist M. The first intensive care unit in the world: Copenhagen 1953. Acta Anaesthesiol Scand 47 (2003) 1190-1195
4. Nollet F., and de Visser M. Postpolio syndrome. Arch Neurol 61 (2004) 1142-1144
5. Gonzalez H., Olsson T., and Borg K. Management of postpolio syndrome. Lancet Neurol 9 (2010) 634-642
6. Farbu E., Gilhus N.E., Barnes M.P., et al. EFNS guideline on diagnosis and management of post-polio syndrome: report of an EFNS task force. Eur J Neurol 13 (2006) 795-801
7. Horemans H.L., Beelen A., Nollet F., Jones D.A., and Lankhorst G.J. Reproducibility of maximal quadriceps strength and its relationship to maximal voluntary activation in postpoliomyelitis syndrome. Arch Phys Med Rehabil 85 (2004) 1273-1278
8. Stolwijk-Swüste J.M., Tersteeg I., Beelen A., Lankhorst G.J., Nollet F., and CARPA Study Group. The impact of age and comorbidity on the progression of disability in late-onset sequelae of poliomyelitis. Arch Phys Med Rehabil 91 (2010) 523-528
9. Nollet F., Beelen A., Twisk J.W., Lankhorst G.J., and De Visser M. Perceived health and physical functioning in postpoliomyelitis syndrome: a 6-year prospective follow-up study. Arch Phys Med Rehabil 84 (2003) 1048-1056
10. Stolwijk-Swüste J.M., Beelen A., Lankhorst G.J., and Nollet F. The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: a systematic review. Arch Phys Med Rehabil 86 (2005) 1693-1701
11. Elovaara I., Apostolski S., van Doorn P., et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol 15 (2008) 893-908
12. Koopman F.S., Beelen A., Gerrits K.H., et al. Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial. BMC Neurol 10 (2010) 8